Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety
Ischemic heart disease is a significant risk factor that threatens human health, and antiplatelet drugs are routinely used to treat cases in clinical settings. Chinese medicine for promoting blood circulation and removing blood stasis (PBCRBSCM) can often be combined with antiplatelet drugs to treat...
Enregistré dans:
Auteurs principaux: | Zongliang Yu, Xiaoya Li, Xiaonan Zhang, Dan Li, Yimeng Gu, Min Wu, Longtao Liu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Hindawi Limited
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a2bc4704f0d14b80a94a51cc6f01dfa5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Correlation between Palpitations below the Heart in Traditional Chinese Medicine and Autonomic Nerve Function Based on Heart Rate Variability: A Case-Control Study
par: Chengcheng Song, et autres
Publié: (2021) -
The Challenges of Ethical Review in Clinical Research of Traditional Chinese Medicine
par: Jie Zhang, et autres
Publié: (2021) -
Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study
par: Zhengwei Huang, et autres
Publié: (2021) -
Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction
par: Huajuan Jiang, et autres
Publié: (2021) -
Efficacy and Safety of Chinese Medicine in Treating Arrhythmia: Meta-Analysis of Randomized Controlled Trials
par: Hanyu He, et autres
Publié: (2021)